Medicare Enrolled

Dr. Diana Ronderos Botero, MD

Pulmonary Disease · Vero Beach, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
3450 11TH CT STE 306, Vero Beach, FL 32960
7727945800
In practice since 2018 (8 years)
NPI: 1568966562 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ronderos Botero from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ronderos Botero? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ronderos Botero

Dr. Diana Ronderos Botero is a pulmonary disease in Vero Beach, FL, with 8 years in practice. Based on federal Medicare data, Dr. Ronderos Botero performed 372 Medicare services across 332 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ronderos Botero received a total of $2,956 from 14 pharmaceutical and/or device companies across 71 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ronderos Botero is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 8 years in practice▲ 372 Medicare services$ $2,956 industry payments

Medicare Practice Summary

Medicare Utilization ↗
372
Medicare services
Bottom 20% in FL for pulmonary disease
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
332
Unique beneficiaries
$75
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~46 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
New patient office visit (45-59 min)115$106$308
Office visit, established patient (20-29 min)59$54$170
Hospital follow-up visit, high complexity48$97$272
Office visit, established patient (30-39 min)36$80$205
Hospital follow-up visit, moderate complexity23$65$170
Test to measure expiratory airflow and volume changes before and after medication administration20$8$542
Test to determine lung volumes using gas dilution or washout20$10$29
Test to examine how well the lungs exchange gases20$7$22
Initial hospital admission, moderate complexity18$107$1,672
New patient office visit (30-44 min)13$69$180
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,956
Total received (2022-2024)
Avg $985/year across 3 years
Top 49% in FL for pulmonary disease
14
Companies
71
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,956 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,997
2023
$894
2022
$66

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Actelion Pharmaceuticals US, Inc.
$1,184
United Therapeutics Corporation
$598
GlaxoSmithKline, LLC.
$364
Bayer Healthcare Pharmaceuticals Inc.
$274
AstraZeneca Pharmaceuticals LP
$201
Amgen Inc.
$72
Takeda Pharmaceuticals U.S.A., Inc.
$53
Regeneron Healthcare Solutions, Inc.
$52
Merck Sharp & Dohme LLC
$49
Pulmonx Corporation
$26
Mylan Specialty L.P.
$25
Penumbra, Inc.
$24
Gilead Sciences, Inc.
$19
ICU Medical Inc
$17
Top 3 companies account for 72.6% of total payments
Associated products mentioned in payments ›
AIRSUPRA · AREXVY · Adempas · BREZTRI · CHARTIS CATHETER · DUPIXENT · FASENRA · GLASSIA · Indigo System · NUCALA · OPSUMIT · ORENITRAM · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · Tracheostomy · UPTRAVI · Veklury · WINREVAIR · YUPELRI
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $795 per 100 Medicare services performed
Looking for a pulmonary disease in Vero Beach?
Compare pulmonary diseases in the Vero Beach area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary Diseases within 10 mi
14
Per 100K population
8.5
County median income
$71,049
Nearest hospital
CLEVELAND CLINIC INDIAN RIVER HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Ronderos Botero is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Ronderos Botero experienced with new patient office visit (45-59 min)?
Based on Medicare claims data, Dr. Ronderos Botero performed 115 new patient office visit (45-59 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ronderos Botero receive payments from pharmaceutical companies?
Yes. Dr. Ronderos Botero received a total of $2,956 from 14 companies across 71 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ronderos Botero's costs compare to other pulmonary diseases in Vero Beach?
Dr. Ronderos Botero's average Medicare payment per service is $75. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ronderos Botero) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →